Treatment of periocular and temporal reticular veins with 1064‐nm Nd:YAG Laser

2020 ◽  
Vol 19 (9) ◽  
pp. 2306-2312
Author(s):  
Tee Sin Lee ◽  
James Wei Ming Kwek ◽  
David A. F. Ellis
Keyword(s):  
2002 ◽  
Vol 19 (1) ◽  
pp. 3-8 ◽  
Author(s):  
Cindy Y. Li ◽  
Sorin Eremia

Objective: Throughout the 1990s, laser treatment of leg veins was a challenge. Newer, longer wavelength lasers capable of delivering high fluences with larger spot sizes with a variable pulse width have shown promising preliminary results. Experience with these lasers for treatment of facial telangiectasia and periorbital reticular veins is even more scant. To our knowledge this is the first prospective study to evaluate a variable pulse width, cryogen spray—equipped 1064 nm Nd:Yag laser for both the treatment of leg and face veins, including larger periorbital reticular veins. Materials and Methods: Forty-seven volunteers aged 32–67 years (30 with skin type I-V with leg telangiectasia and reticular veins, and 17 with skin type I-IV with face telangiectasia and reticular periorbital veins) were treated with the Nd:Yag laser. For leg vein patients, 2–3 sets of different leg veins were treated with a maximum of 3 treatments. Patients were examined 1 week after each treatment and at 1, 2, and 3 months after the last treatment. All face vein patients received 1 treatment and were examined at 1 month posttreatment. Treatment parameters for both leg and face veins varied with the size of vessels being treated. Pre- and posttreatment 35 mm photos were taken. Improvement was judged by 2 experienced physicians both visually on patients and by comparison of pre- and posttreatment photos. Results were graded as percent resolution in 5 groups: 0%, 0–25%, 25–50%, 50–75%, and 75–100%. Results: Twenty-three of 30 patients completed the leg vein segment of the study. A total of 41 leg vein sites were treated. Greater than 75% improvement was observed at 85% of the treated sites. Greater than 50% improvement was observed at 95% of the treated sites. Less than 25% improvement was observed at 5% of the treated sites. Seventeen of 17 patients completed the face vein segment of the study, and 32 sites were treated (24 cheeks, noses, and chin telangiectasia and 8 periorbital reticular veins). Greater than 75% improvement was observed at 97% of the treated sites. Greater than 50% improvement was observed at 100% of the treated sites. Notably, 100% of the facial reticular veins treated had essentially 100% resolution. Pain during treatment was variably perceived by patients, but was occasionally sufficient for patients to decline further treatment. Transient hemosiderin pigmentation, as seen with sclerotherapy, was common with larger vessels. Conclusion: The cryogen spray-equipped 1064 nm Nd: Yag laser was remarkably effective and safe for skin type I-V patients. Excellent results for leg veins, approaching sclerotherapy outcomes, were obtained for both 0.3–1.5 mm telangiectasia and larger 1.5–3.0 mm reticular veins. Furthermore, this 1064 Nd:Yag laser is also an outstanding tool for treatment of facial telangiectasia with little if any risk of purpura. For the first time we appear to have a safe and effective treatment for 1–2 mm periorbital reticular veins. The use of topical anesthesia may be needed for some patients.


Phlebologie ◽  
2019 ◽  
Vol 49 (01) ◽  
pp. 16-22
Author(s):  
A. A. M. Fratila ◽  
G. G. Gauglitz ◽  
A. Strohbücker ◽  
D. Radu

AbstractThe therapy of spider veins, telangiectasia and reticular veins of lower extremities can be successfully performed with sclerotherapy or by using the long pulsed (LP) Nd:YAG laser. A matter of discussion, however, is how should laser parameters – such as wavelength, fluence, pulse duration, number of pulses – be utilized for effective and selective photothermolysis treatment without any side effects. The selective photothermolysis was introduced in 1983 by Anderson and Parrish 1 as a concept in laser treatment, meaning the selective thermal destruction of the target tissue (the chromophores – the light-absorption molecule is here the blood vessel) using a specific laser light wavelength, with minimal injury to surrounding tissue (the skin). The effectiveness of the selective photothermolysis process using an LP Nd:YAG laser at 1064 nm for the treatment of leg veins telangiectasias up to 2 mm in diameter, is the result of 30-years clinical experience sustained by patient satisfaction and photo documentation. The use of double and triple pulses seems to be the key of success in treating even larger vessels and has demonstrated superior safety and efficacy. Even bigger telangiectasias, reticular veins or other dilated veins on neckline, upper abdomen or in the face can be successfully treated with the LP Nd:YAG laser.


2002 ◽  
Vol 28 (3) ◽  
pp. 220-223
Author(s):  
ARLENE S. ROGACHEFSKY ◽  
SIRUNYA SILAPUNT ◽  
DAVID J. GOLDBERG

VASA ◽  
2011 ◽  
Vol 40 (3) ◽  
pp. 235-240 ◽  
Author(s):  
Krnic ◽  
Sucic

Background: The aim of this study is to report our results in main stem vein closure using the bipolar radiofrequency induced thermotherapy (RFITT) system and the 1064nm Nd:Yag laser. Patients and methods: 44 incompetent main stem veins (37 great saphenous veins, one lesser saphenous vein, and 6 anterior accessory saphenous veins) in 29 patients were treated using RFITT. 53 incompetent main stem veins (45 great saphenous veins, 4 lesser saphenous veins, and 4 anterior accessory saphenous veins) in 43 patients were treated endovenously with 1064 nm Nd:Yag laser. All patients underwent postoperative duplex scanning within a month after procedure, as well as a short interview regarding postoperative discomfort. Results: In main stem veins treated with RFITT, the success rate within the first month was 86,4 % (38 out of 44 veins). Complete failure rate was 13,6 % (6 out of 44 veins). In 53 main stem veins treated by 1064 nm Nd:Yag laser, the success rate was 100 %, consisting of 98,1 % complete success (52/53 veins), and 1,9 % partial success (1/53 veins). None of the patients treated with RFITT experienced postoperative adverse effects, whereas 13/43 (30,2 %) patients treated with laser had to use oral analgesics after the treatment, and 21/43 (48,8 %) patients reported transient skin changes, such as bruising or skin redness. Conclusions: RFITT system was fairly efficient in the short term for closure of main trunk veins, whereas longer term results are still scarce. Postoperative side effects of RFITT were minimal. 1064nm Nd:Yag laser, according to short term results, proved to be very effective for main stem vein closure. Postoperative side effects related to 1064 nm Nd:Yag endovenous laser treatment proved to be minor, transient, and acceptable.


Sign in / Sign up

Export Citation Format

Share Document